HIT anticipates strong growth in 2026 and provided revenue guidance of $45m-$50m, a ~35%-50% y/y anticipated advance. The company is focused on scaling and accelerating adoption of its platform and plans to boost spending in 1H26 to enhance and market the platform. We expect growth to accelerate in the back half of 2026 into 2027. We also expect substantial operating leverage as HIT continues to scale its AI-driven platform. The company is optimistic about its underwriting prospects in larger employer segments of the market, as well as a 3-year rate stabilization program expected to launch in 1H 2026.
01 Apr 2026
HIT: Laying the Groundwork for Strong YE 2026 & Acceleration into 2027
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
HIT: Laying the Groundwork for Strong YE 2026 & Acceleration into 2027
Health In Tech, Inc. Class A (HIT:NAS) | 0 0 0.0%
- Published:
01 Apr 2026 -
Author:
Marla Backer -
Pages:
11 -
HIT anticipates strong growth in 2026 and provided revenue guidance of $45m-$50m, a ~35%-50% y/y anticipated advance. The company is focused on scaling and accelerating adoption of its platform and plans to boost spending in 1H26 to enhance and market the platform. We expect growth to accelerate in the back half of 2026 into 2027. We also expect substantial operating leverage as HIT continues to scale its AI-driven platform. The company is optimistic about its underwriting prospects in larger employer segments of the market, as well as a 3-year rate stabilization program expected to launch in 1H 2026.